Denmark vs Europe (WHO region): Estimated antiretroviral therapy coverage among people living with HIV
Denmark
94.0%
in 2024
Europe (WHO region)
67.0%
in 2025
Denmark rank
11th
Europe (WHO region) rank
8th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Denmark
- Europe (WHO region)
How they compare
Denmark currently reports 94.0% against 67.0% in Europe (WHO region), a difference of 27.0%.
That makes Denmark's figure about 1.4 times Europe (WHO region)'s.
Across all 25 years both countries report, Denmark has been ahead every year.
Denmark ranks 11th and Europe (WHO region) ranks 8th of 143 countries.
Denmark has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Denmark | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.1% | 25.3% | 24.8% | Denmark |
| 2010s | 76.8% | 46.4% | 30.4% | Denmark |
| 2020s | 90.6% | 64.6% | 26.0% | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Denmark or Europe (WHO region)?
- Denmark, at 94.0% against 67.0% in Europe (WHO region) as of 2024.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Denmark and Europe (WHO region)?
- 27.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Europe (WHO region)?
- 25 years are reported by both, from 2000 to 2024.
- How do Denmark and Europe (WHO region) rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Denmark ranks 11th and Europe (WHO region) ranks 8th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.